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Abstract
Retroviral Gag proteins function during early and late stages of the viral life cycle. To gain additional insight into the cellular
requirements for viral replication, a two-hybrid screen was used to identify cellular proteins that interact with the Mason–Pfizer monkey
virus Gag protein. One of the cellular proteins found was identified as hUbc9, a nuclear pore-associated E2 SUMO conjugating enzyme.
In vitro protein interaction assays verified the association and mapped the interaction domain to the CA protein. In vivo, hUbc9 and Gag
colocalized in the cytoplasm as discrete foci near the nuclear membrane. In addition, overexpression of hUbc9 in cells caused a fraction of
Gag to colocalize with hUbc9 in the nucleus. These experiments demonstrate that hUbc9 and Gag interact in cells, strengthen the hypothesis
that Gag proteins transiently associate with the nuclear compartment during viral replication, and suggest that hUbc9 plays a role in this
process.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Retroviral Gag proteins play critical roles during early
and late stages of the viral life cycle. It is clear from
numerous studies that Gag proteins drive virus assembly
and can do so when expressed in the absence of all other
viral components. Thus, Gag contains the necessary struc-
tural information for intracellular transport, assembly of the
immature capsid shell, plasma membrane binding, and bud-
ding. Gag proteins are also responsible for packaging the
unspliced viral RNA, the pol gene encoded reverse tran-
scriptase (RT) and integrase (IN) enzymes and the env gene
encoded viral glycoproteins. Either during or shortly after
budding, Gag is cleaved by the viral protease into the
internal structural and enzymatic proteins of the mature
infectious virion. These include MA (matrix), CA (capsid),
and NC (nucleocapsid). For many retroviruses, additional
Gag-derived polypeptides are found in the mature virion but
their precise locations and functions within the mature
virion are not fully understood.
Gag proteins are also thought to function during entry
into a new cell. They have been found to be components of
the preintegration complex (PIC) and many mutations in the
gag genes of various retroviruses have no obvious effect on
assembly but rather block replication during early stages of
infection (Alin and Goff, 1996; Crawford and Goff, 1984;
Parent et al., 1996; Scheifele et al., 2002; Yasuda and
Hunter, 1998; Yu et al., 1992). It is, therefore, reasonable to
suspect that Gag proteins play active roles in the processes
of uncoating, reverse transcription, transportation of the PIC
to the nuclear compartment, or integration.
Mason–Pfizer monkey virus (MPMV) is the prototypical
betaretrovirus. As with other betaretroviruses, the MPMV
Gag polyproteins assemble into immature procapsids in the
cytoplasm, near the nuclear membrane. Once assembled,
the procapsids are actively transported to the plasma mem-
brane from which they bud. Unlike all other retroviruses
that assemble and bud concomitantly at the plasma mem-
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brane, the processes of betaretrovirus capsid assembly, cy-
toplasmic transport, membrane binding, and budding are
separate events. Indeed many mutations in MPMV Gag
have been found which specifically block each of these
morphogenic events (reviewed in Hunter, 1994; Sakalian
and Hunter, 1999; Weldon and Hunter, 1996). Other point
mutations have been found which convert the MPMV mor-
phogenic pathway to one that resembles other retroviruses
such as HIV-1 and RSV (Rhee and Hunter, 1991). For these
reasons, MPMV serves as an excellent model for determin-
ing the many molecular events during retrovirus replication.
During virus maturation, the MPMV Gag precursor
polyproteins are cleaved by the viral protease into the indi-
vidual structural proteins. These include MA, pp24, p12,
CA, NC, and p4. The phosphoprotein pp24 is further
cleaved into pp18 and pp16. The function of pp18 protein is
not known but appears to be important for early replicative
events. pp16 contains the late budding motif (L) and is
required for particle release (Yasuda and Hunter, 1998;
Yasuda et al., 2002). The p12 protein is also important
during assembly, where it appears to provide a scaffolding
function for efficient assembly (Sakalian and Hunter, 1999;
Sommerfelt et al., 1992).
It has become evident that Gag proteins function during
virus replication via interactions with host cell com-
ponents (Weldon et al., 1998). KIF4, a member of the
kinesin family of microtubule-associated motor proteins,
has been found to interact with the Gag proteins of HIV-1,
MLV, and MPMV in two-hybrid assays (Kim et al., 1998).
These findings, along with the observations that actin and
other cytoskeletal proteins are packaged into retrovirus par-
ticles (Ott et al., 1996), have led to the hypothesis that Gag
proteins are transported through the cytoplasm along the
cytoskeletal network. Virion release requires functional in-
teractions between Gag L domains and cellular proteins
involved in ubiquitin ligation, NEDD4 and BUL1, or in late
endosomal trafficking, TSG101 and Vsp4 (Demirov et al.,
2002; Garrus et al., 2001; Kikonyogo et al., 2001; Martin-
Serrano et al., 2001; Myers and Allen, 2002; Pornillos et al.,
2002; Strack et al., 2000; VerPlank et al., 2001; Yasuda
et al., 2002). Chaperonins and chaperonin-associated pro-
teins, TriC, Hsp70, and Ubp, have been found to interact
with MPMV and HIV-1 Gag proteins and it has been
suggested that these cellular proteins assist in folding
Gag proteins into a conformation(s) required for capsid
assembly (Callahan et al., 1998; Gurer et al., 2002; Handley
et al., 2001; Hong et al., 2001). HEED, the human ho-
molog of mouse eed (Peytavi et al., 1999), translation elon-
gation factor 1-alpha (Cimarelli and Luban, 1999), HO3,
a putative tRNA synthetase (Lama and Trono, 1998),
and hIF2, a human homolog of bacterial translation initia-
tion factor 2 are known to interact with the HIV MA protein
and provide essential replicative functions. However, the
roles these proteins play during viral replication are not
known.
Gag-interacting cellular proteins are also thought to be
essential for virus replication during the early stages of the
viral life cycle. Cyclophilin A, a prolyl isomerase thought to
function as a chaperonin, is incorporated into HIV-1 parti-
cles via interactions with Gag. This incorporation enhances
viral infectivity (Braaten et al., 1996; Luban et al., 1993).
The antiviral Fv1 gene product interacts with the CA protein
of MLV and abrogates integration at a postentry step (Goff,
1996; Rosenberg and Jolicoeur, 1997). It has also been
suggested that the Gag-interacting nuclear shuttling pro-
teins, Van and CRM-1, regulate nuclear import of the
HIV-1 and RSV PICs (Bacharach et al., 2000; Gupta et al.,
2000; Scheifele et al., 2002). It is likely that many other
cellular proteins interact with Gag proteins and are involved
in retrovirus replication.
To gain more insight into the cellular requirements for
viral replication, we utilized a two-hybrid screen to search
for cellular proteins that interact with the MPMV Gag
protein. We show that MPMV Gag specifically interacts
with hUbc9, a nuclear pore-associated, E2 SUMO conju-
gating enzyme. Sumoylation is the process of covalently
attaching a SUMO moiety to a target protein (Melchior,
2000; Wilson and Rangasamy, 2001). SUMO is small pro-
tein (101 amino acids) with amino acid sequence similarity
to ubiquitin (Lapenta et al., 1997). While ubiquitination and
sumoylation are biochemically analogous processes, they
are different enzymatic pathways leading to alternative bi-
ological roles. While polyubiquitination targets proteins for
degradation, sumoylation does not. Instead, Ubc9, through
its SUMO conjugase activity, (i) controls intracellular traf-
ficking of substrate proteins to the nuclear compartment
(Bhaskar et al., 2000; Duprez et al., 1999; Rangasamy et al.,
2000) or the mitotic spindle (Joseph et al., 2002; Saitoh et
al., 1997, 1998); (ii) facilitates protein–protein interactions
(Subramanian et al., 2003); or (iii) facilitates protein func-
tion (Desterro et al., 1998; Giorgino et al., 2000; Rodriguez
et al., 1999; Tashiro et al., 1997). Other reports indicate that
Ubc9 may have the capacity to function independently of its
enzymatic activity. Vsx-1, for example, is a paired-like
homeobox transcription factor that requires an interaction
with Ubc9 for nuclear localization yet is not sumoylated
(Kurtzman and Schechter, 2001).
Here we describe the interaction of hUbc9 with the
MPMV Gag precursor polyprotein, Pr78, and the Gag-
cleavage product CA. We demonstrate that these interac-
tions take place in vitro using GST pull-down and coim-
mune precipitation assays and show that hUbc9 and Gag
proteins clearly colocalize in the cytoplasm as discrete foci
near the nuclear membrane. In addition, we found that
overexpression of hUbc9 in cells caused a fraction of Gag to
colocalize with hUbc9 in the nucleus. These experiments
demonstrate that hUbc9 and Gag interact in cells and raise
the possibility that Gag proteins, through interactions with
hUbc9, transiently associate with the nuclear compartment
during viral replication.
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Results
Identification of hUbc9 as a MPMV Gag-interacting
protein
To identify MPMV Gag-interacting proteins, a Gal4-
based, yeast two-hybrid system programmed with the full-
length Gag as a bait was used to screen a HeLa cDNA
library. Yeast were transformed with the pAS.Gag bait
plasmid and the cDNA library expression plasmids. A total
of 2.5  107 clones were screened. Of these clones, 348
were initially found to activate both reporter genes, HIS3
and LacZ. From the initial candidate clones obtained, 212
clones were reconfirmed after three rounds of replating on
selective media containing increased amounts of 3-amin-
otriazole 3-AT (15 mM) to block leaking HIS3 expression.
Candidate library plasmids were retransformed into yeast
either by itself, with the empty bait plasmid, pSD2.1, or into
yeast containing pAS.Gag. Twenty-five clones reproducibly
activated the lacZ and HIS3 reporter genes only in the
presence of the pAS.Gag. DNA sequence analysis of the 25
prey plasmids revealed that 15 of the clones contained a
nearly identical 5 untranslated region (average length of
125 bp), a 3 untranslated region of 564 bp, and an open
reading frame of 474 bp encoding a 158 amino acid protein
with an estimated molecular weight of 18 kDa. Comparison
of the open reading frame sequence with sequences in
GenBank databases demonstrated 100% identity to hUbc9,
a human homologue of the E2 Sumo-conjugating enzyme
Ubc9 in yeast (Hateboer et al., 1996; Wright et al., 1996). In
addition, 9 of the 25 initial clones contained a common open
reading frame identical to Tsg101, which has been previ-
ously shown to interact with the late budding domains of
HIV-1 and HIV-2 Gag and the ebola virus p40 protein and
facilitate virus egress (Demirov et al., 2002; Garrus et al.,
2001; Martin-Serrano et al., 2001; Myers and Allen, 2002;
Pornillos et al., 2002; VerPlank et al., 2001). The hUbc9
clone, G10B, was chosen for further studies because it
contained minimal upstream (116 bp) and downstream (553
bp) noncoding regions and a complete, non-permutated cod-
ing region. As shown in Table 1, expression of Ubc9–
Gal4AD fusion proteins in yeast activated the -galactosi-
dase reporter gene in the presence of MPMV Gag and p53
but not in yeast harboring either the empty bait plasmid
pAS2.1 or a plasmid encoding Gal4BD–human lamin C.
The observation that coexpression of Ubc9 and p53 acti-
vated the reporter gene was expected because these two
proteins are known to interact (Lin et al., 2002; Rodriguez
et al., 1999; Shen et al., 1996).
MPMV Gag–hUbc9 interactions
The results of the yeast two-hybrid experiments were
verified by testing whether hUbc9 and Gag interact in vitro.
For this, GST pull-down and coimmune precipitation ex-
periments were performed using hUbc9–GST fusion pro-
teins and MPMV Gag proteins derived from the following
several different sources: (1) in vitro transcription/transla-
tion reactions: (2) cell lysates; and (3) detergent-solubilized
virions.
There are several published reports that describe the use
of GST fusion proteins to pull-down Gag proteins from
different retroviruses (Bacharach et al., 2000; Callahan et
al., 1998). However, we found in preliminary experiments
that MPMV Gag bound to GST just as efficiently as it did
to hUbc9–GST in standard “GST pull-down” buffers. To
prevent these nonspecific interactions, equal molar-amounts
of GST and hUbc9–GST fusion proteins bound to gluta-
thione–Sepharose beads (12 and 17 g, respectively) were
incubated with BSA for 15 min and then incubated for 8 h
at 4°C with Pr78 translated in vitro from pET.M100A
(Sakalian and Hunter, 1999). After washing the beads, pro-
teins bound to the beads were eluted and analyzed by
Western blot analysis using antibodies against Pr78. Under
these conditions, Pr78 did not bind to either the glutathione
sepharose beads or the immobilized GST protein alone. In
contrast, Pr78 bound to the hUbc9–GST fusion protein (Fig.
1A). Based on the amount of Pr78 added to these reactions
as well as in subsequent repeated experiments (repeated five
times, data not shown), hUbc9–GST was estimated to bind
approximately 2–3% of the input Pr78. The inability of
hUbc9–GST to associate with more than 1–2% of the input
Pr78 was not due to limiting amounts of the fusion protein
in the assay because hUbc9–GST was added in 100-fold
excess to the amount of Pr78. When the nonbound fraction
of the initial pull-down was retested for hUbc9–GST bind-
ing under the same conditions, essentially the same amount
of Pr78 bound to hUbc9–GST (data not shown). These
results suggest that the inability of Ubc9–GST to pull down
more than 2–3% of the input Pr78 either reflects weak
binding or reflects that during dynamic protein conforma-
tional changes of Pr78 in solution, only a certain fraction
assumes a conformation that is competent for Ubc9 binding.
Table 1
Gag–Ubc9 interactions in the yeast two-hybrid system
Bait protein
(plasmid)
Prey protein
(plasmid)
-Galactosidase assay
Filtera Liquid
Empty vector (pAS2.1) Empty vector (pACT2)  0.39  0.04
Gag (pASGag) Empty vector  0.12  0.01
Empty vector Ubc9 (pG10B)  1.13  0.66
p53 (pVA3) T Ag (pTD1)  22.83  1.00
Gag Gag (pMPAD)  17.12  1.28
Gag Ubc9  11.35  1.18
p53 Ubc9  8.74  0.6
Lamin C Ubc9  n.d.
Note. Three independent cotransformations were tested for -galactosi-
dase activity (filter and liquid assays). Each bait protein was expressed in
yeast as C-terminal fusions proteins with the Ga14 DNA-binding domain.
a -gal filter assays are reported as , no visible color after 18 h
incubation; , visible blue color after 4 h incubation; , visible blue
color after 2 h incubation. n.d., not done.
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Nonetheless, these results substantiate the observation that
Pr78 interacts with hUbc9.
Further validation of the specific interaction between
Pr78 and Ubc9 was obtained with GST pull-down experi-
ments using transfected cell lysates. HeLa cells were mock
transfected or transfected with an infectious proviral clone,
pSARM4. At 72 h posttransfection, cells were lysed and
incubated with hUbc9–GST–Sepharose and GST–Sepha-
rose beads for 8 h at 4°C in the presence of excess BSA.
Proteins bound to the beads were eluted and Gag proteins
were detected by Western blot analysis using anti-Pr78
antibodies. Again, hUbc9–GST bound significantly more
Pr78 (Fig. 1B, lane 4) than did GST-only beads (Fig. 1B,
lane 3). These results further confirm that hUbc9 is capable
of interacting with Pr78.
The basis for the interactions between hUbc9 and Pr78
was studied further by mapping the region of Pr78 that
binds to hUbc9. For these studies, 60 ng of virion-associ-
ated, Gag cleavage proteins were extracted from purified,
infectious virions and incubated with either equal molar
amounts of hUbc9–GST (17 g) or GST-only (12 g)
bound beads. Gag proteins bound to the beads were ana-
lyzed by Western blots as before. One-tenth of the amount
of virion-derived proteins added to the pull-down reactions
was directly loaded on the acrylamide gel as loading and
antibody controls (Fig. 1C, lane 3). We found that hUbc9–
GST (Fig. 1C, lane 2), but not GST only (lane 1), was able
to pull down several Gag-related proteins, CA (p27) and NC
(p14). The identity of the 30-kDa protein is assumed to be
an intermediate Gag cleavage product. It is important to
remember that Pr78 is cleaved by the viral protease during
or shortly after particle release into equal molar amounts of
MA, pp24, p12, CA, NC, and p4. However, as can be seen
in Fig. 1C (lane 3), the antiserum used here did not react
well with pp24 from purified virions. We, therefore, could
not determine whether the low amount of pp24 observed in
the pull-down reactions (Fig. 1C, lane 2) is a reflection of
weak interactions between pp24 and hUbc9 or inadequate
antibody binding to pp24, or whether pp24 is being pulled
down in this assay via interactions with CA and not Ubc9.
Fig. 1. In vitro interactions between MPMV Gag to Ubc9. (A) Binding of hUbc9-GST to in vitro translated Pr78. GST-bound glutathione–Sepharose beads
(lanes 1 and 5), hUbc9-GST-beads (lanes 2, 4, and 6), or glutathione–Sepharose beads only (lane 3) were incubated in buffer only (lanes 1 and 2), a rabbit
reticulocyte lysate (lane 4), or rabbit reticulocyte lysates containing pET.M100A, which encodes Pr78 (lanes 3, 5, and 6). Proteins bound to the beads were
separated by SDS–PAGE. As a loading control, 1/10 of the amount of in vitro translated Pr78 added to the pull-down assays was loaded directly onto the
gel (lane 7). Gag-related proteins were detected by immunoblotting with anti-Pr78 antibodies (A–D) and their positions are indicated. (B) Binding of
hUbc9-GST to Pr78 expressed in HeLa cells. Lysates prepared from either untransfected HeLa cells (lanes 1 and 2) or HeLa cells transfected with pSARM4
(lanes 3 and 4) were incubated with either GST beads (lanes 1 and 3) or hUbc9-GST beads (lanes 2 and 4). Bound proteins were analyzed as described for
(A). (C) Binding of hUbc9-GST to MPMV virion proteins. Purified MPMV virions were solublized with 0.5% TX-100, incubated with either GST-beads
(lanes 1) or hUbc9-GST-beads (lane 2), eluted, and separated by SDS–PAGE. As a loading control, 1/10 of the amount of virions added to the pull-down
assays was run directly on SDS–PAGE (lane 3). (D) RNAse A digestion of MPMV-hUbc9-GST protein complexes reduces NC binding. To determine if
virion-derived NC interacts indirectly with hUbc9-GST via RNA, Rnase A (5 g) was included in the binding reactions (lane 5) as described above. All other
lanes were identical to those described for (C) and their contents are indicated.
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Nonetheless, these results suggest that either Pr78 contains
multiple Ubc9-binding sites or that one or more of these
Gag-cleavage products indirectly interacts with the hUbc9-
GST Sepharose beads.
Because NC is an RNA-binding protein, we considered
the possibility that NC might associate with the hUbc9–
GST beads via RNA and not through direct protein–protein
interactions. To test this hypothesis, hUbc9–GST (Fig. 1D,
lanes 2, 4, and 5) and GST alone (lanes 1 and 3) -bound
glutathione–Sepharose beads were incubated with virion-
derived Gag proteins in the presence or absence of exog-
enously added RNase A. Gag proteins bound to the resins
after RNA digestion was analyzed by immunoblotting as
before (Figs. 1A–C). Again, CA and NC proteins specifi-
cally bound to the hUbc9–GST fusion protein in the ab-
sence of RNase A (Fig. 1D, lane 4). As expected, the
addition of RNase A did not change the amount of CA
bound to hUbc9. In contrast, the amount of NC bound was
reduced in the presence of RNase A (Fig. 1D, lane 5). These
results suggest that the majority of NC binds to the beads
via RNA and not directly to Ubc9. The nature of the inter-
actions observed between hUbc9 and CA and pp24 (i.e.,
direct or indirect binding) is currently being investigated.
Further verification of Ubc9–Gag interactions was ob-
tained by coimmunoprecipitation experiments. To this end,
cell lysates and solubilized virions from mock-transfected
HeLa cells and HeLa cells transfected with pSARM4 were
incubated with equal molar amounts of soluble hUbc9–GST
or GST alone. Protein complexes were immuno precipitated
using anti-Pr78 antibodies and analyzed by immunoblotting
with anti-GST antibodies. As shown in Fig. 2, low levels of
hUbc9–GST and GST alone bound proteins were detected
in untransfected cell lysates (lanes 1 and 2) and media (lanes
3 and 4). However, significantly more hUbc9–GST was
precipitated from infected cell lysates (lane 4) and virions
(lane 7) than was GST (lanes 3 and 8). We have, therefore,
used several different experimental procedures to demon-
strate that hUbc9 specifically interacts with MPMV Gag
proteins in vitro.
Ubc9 is not incorporated into MPMV virions
Many but not all cellular proteins found to interact with
Gag proteins are packaged into virions either passively due
to their interactions with Gag at the site of assembly (e.g.,
Tsg101) (Myers and Allen, 2002; Demirov et al., 2002) or
actively because they are thought to provide preintegrative
functions (e.g., cyclophilin A)(Braaten et al., 1996). We,
therefore, examined whether hUbc9 is packaged into virus
particles. MPMV virions were purified from chronically
infected CMMT cells by isopycnic and subsequent velocity
sucrose gradients and then digested with subtilisin to re-
move any proteins that copurified with but were not con-
tained within virus particles. After digestion, virions were
purified through a 20% sucrose cushion and equal amounts
of proteins in the pellets were analyzed by immunoblotting
using antibodies directed against either Pr78 or hUbc9.
Several controls were included in this experiment. Unin-
fected cell lysates served as antibody controls. The second
control was an assay to screen for the presence of Tsg101 in
MPMV virions. Since Tsg101 was identified in our two-
hybrid screen as a putative MPMV Gag-interaction partner
and because it has been detected in purified HIV-1 and 2
virions (Demirov et al., 2002; Myers and Allen, 2002), we
expected to find Tsg101 within MPMV virions. As shown in
Fig. 3, all of the Gag-cleavage products were found in
virions but not in uninfected cells lysates (lanes 1 and 2).
The 27-kDa band detected in the untransfected sample is
due to inadvertent spill over of the sample during the load-
ing of the gel. As expected, Tsg101 was also found in cell
Fig. 3. Tsg101, but not Ubc9, is packaged into MPMV virions. Uninfected
cells (L) were lysed in SDS–PAGE sample buffer (lanes 1, 3, and 5).
Purified MPMV virions (V) were digested with 10 mg/ml subtilisin for 4 h
at room temperature, purified by centrifugation through a 20% sucrose
cushion, and solublized in SDS–PAGE sample buffer (lanes 2, 4, and 6).
Cellular and viral proteins were analyzed by immunoblotting with poly-
clonal anti-Pr78 (lanes 1 and 2), monoclonal anti-Ubc9 (lanes 3 and 4), or
monoclonal anti-Tsg101 (lanes 5 and 6) antibodies. The locations of the
viral proteins (CA, pp24, NC, MA, and p12), hUbc9 and Tsg101 are
indicated. The protein present in lane 1 is the result of spillover during the
loading of the gel.
Fig. 2. Coimmunoprecipitation of MPMV Gag and soluble hUbc9-GST.
HeLa cells were either mock transfected (lanes 1, 2, 5, and 6) or transfected
with 2 g of wild-type proviral MPMV DNA, pSARM4 (lanes 3, 4, 7, and
8). At 48 h posttransfection, cell-culture media were harvested and cell
lysates (lanes 1–4) were prepared. Media samples were centrifuged
through a 20% sucrose cushion and the pellets were lysed (lanes 5–8).
Samples were incubated with equal molar amounts of soluble GST and
hUbc9–GST fusion proteins for 8 h at 4°C. Proteins were collected by
immunoprecipitation using polyclonal antibodies to Pr78. Immune precip-
itates were separated by electrophoreses and analyzed by immunoblotting
with HRP-conjugated anti-GST antibodies. Positions of Ubc9-GST and
GST are indicated on the right.
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lysates and virions (Fig. 3, lanes 5 and 6). In contrast, while
hUbc9 was easily observed in uninfected cell lysates (lane
3), it was not packaged into virions at a detectable level
(lane 4). Thus, if hUbc9 interacts with Pr78 in cells, it is not
packaged into viral particles at significant levels.
Colocalization of Ubc9 and MPMV Gag proteins
hUbc9 has been found in several different subcellular
compartments. In yeast and Drosophila, Ubc9 localizes
within the nucleoplasm (Joanisse et al., 1998; Seufert et al.,
1995). In mammalian cells, Ubc9 is also found in the nu-
cleus but it is particularly prominent on the cytoplasmic side
of the nuclear membrane as a component of the nuclear pore
fibrils (Lee et al., 1998; Melchior, 2000; Saitoh et al., 1997,
1998, 2002; Zhang et al., 2002), where it is thought to
control intracellular targeting of substrate proteins either
directly through protein interactions or indirectly via
sumoylation (Kurtzman and Schechter, 2001; Yeh et al.,
2000). This subcellular distribution of Ubc9, the ability of
Pr78 to form stable complexes with hUbc9, and fact that
Pr78 assembles into procapsids on the cytoplasmic side of
the nuclear membrane suggested that the Gag and Ubc9
might colocalize. To test this hypothesis, we transfected
COS-1 cells with pCMV.Myc-Ubc9 alone or together with
pSARM4 and examined the cells by confocal microscopy
using antibodies to Gag and to Ubc9. As has been observed
for endogenous hUbc9, HA-tagged Ubc9, and Ubc9-GFP
fusion proteins (Ahn et al., 2001; Rodriguez et al., 2001;
Saitoh et al., 2002), our Myc-tagged hUbc9 localized to the
nucleus (excluding the nucleolus) and in the cytoplasm near
the nuclear membrane as distinct foci when expressed alone
(Figs. 4A and B). Thus, the addition of the Myc tag to the
amino-terminal end of hUbc9 did not affect its subcellular
localization.
The subcellular distribution of Pr78 was observed in
cells expressing normal levels of hUbc9 and in cells over-
expressing Myc-Ubc9. In cells with normal levels of hUbc9,
Pr78 primarily showed a speckled cytoplasmic staining pat-
tern (Figs. 4D and G). Interestingly, Pr78 was also consis-
tently found in nucleus (albeit at low levels) in these cells.
In COS-1 expressing both Pr78 and Myc-Ubc9, the Gag
signal closely paralleled the hUbc9 signal; there were very
conspicuous areas of colocalization in the cytoplasm near
the nuclear membrane as well as within the nucleus (Figs.
4C–E). In fact, we consistently observed more Gag-specific
signals in the nuclei of cells overexpressing Myc-hUbc9
than we did in cells expressing normal levels of hUbc9.
Finding a similar pattern of Gag-hubc9 colocalization in
HeLa cells (Figs. 4D–H) argues that the association of Gag
with the nuclear compartment is not restricted to COS-1
cells. Furthermore, the hUbc9-specific targeting of Gag to
the nuclear compartment indicates that Gag and hUbc9
interact in cells. Whether our findings are influenced by
Ubc9 overexpression is currently being investigated.
There is precedence for Gag proteins to transiently as-
sociate with the nuclear compartment. In a recent study,
Scheifele et al. showed that the RSV Gag protein localized
in the nucleus of cells treated with leptomycin B, which
blocks CRM-1-mediated nuclear export (Scheifele et al.,
2002). Similarly, HIV-1 Gag proteins were found to accu-
mulate in the nucleus of cells overexpressing either the
nuclear shuttling protein, Van, or a HIV-1 Gag protein
containing a mutation that disrupts a nuclear export signal in
the MA domain (Dupont et al., 1999; Gupta et al., 2000).
Nonetheless, the nuclear association of MPMV Gag seen
here was surprising because this has never been reported. To
further support our observations, we looked for conditions
that might accentuate the nuclear association of Gag without
overexpressing hUbc9. Because nuclear import and export
are ATP-dependent processes, we reasoned that if Gag nor-
mally transits through the nuclear compartment, then Gag
might accumulate in or around the nucleus of cells under
conditions of ATP depletion. To test this hypothesis,
MPMV-infected CMMT cells were treated with sodium
azide and 2-deoxy-D-glucose for 1 h to deplete intracellular
ATP. These conditions have been previously shown to de-
plete ATP without affecting cell viability (Weldon et al.,
1998). The cells were then fixed and the subcellular distri-
bution of Gag was observed by confocal microscopy using
a focal z-section through the nucleus. As expected, Gag was
largely, but not completely, excluded from the nucleus of
untreated cells (Figs. 4I and L). In contrast, Gag was ob-
served to localize to the nuclear compartment (both within
and around the nucleus) under conditions of ATP depletion
(see arrow, Figs. 4K and M). Thus, the nuclear targeting of
Gag is not exclusively linked to overexpression of Myc-
hUbc9. Furthermore, these results are similar to the findings
that the Gag protein of RSV accumulates within the nucleus
when the cellular CRM-1 nuclear export pathway was
blocked using leptomycin B and with the hypothesis that a
fraction of Gag proteins might normally transit through the
nuclear compartment during virus replication (Scheifele et
al., 2002). Whether MPMV Gag also accumulates within
the nucleus during leptomycin B treatment is currently be-
ing investigated.
Discussion
Many of the diverse functions of Gag proteins, from
driving virus assembly to assisting in early replicative
events, have been well characterized over the last several
decades (Craven and Parent, 1996; Freed, 1998; Hunter,
1994; Weldon and Hunter, 1996; Wills and Craven, 1991).
In more recent years, many laboratories have focused their
efforts on identifying and characterizing host cell compo-
nents utilized by Gag proteins during the various stages of
the virus life cycle. The aim of this study was to gain insight
into retrovirus replication through an analysis of virus–host
interactions by identifying host cell proteins that interact
with MPMV Gag. In this article, we describe the discovery
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that hUbc9 interacts specifically with MPMV Gag. The
specificity of the interaction observed in yeast was substan-
tiated by several experimental findings. First, purified
hUbc9–GST fusion proteins specifically bound Gag precur-
sor polyproteins obtained from in vitro translation reactions
and transfected cell lysates. Moreover, purified hUbc9–
GST was found to interact with the capsid protein when
incubated with solubilized virions. Second, hUbc9 could be
coimmunoprecopitated with Gag proteins using anti-Pr78
antibodies. Finally and importantly, coexpression of Myc-
hUbc9 and Gag in COS-1 and HeLa cells revealed a repro-
ducible colocalization in the cytoplasm most notably as foci
or speckles closely associated with nuclear membrane and
to a lesser extent within the nuclear compartment. Whether
these cytoplasmic complexes consist solely of Ubc9 and
Pr78 is currently being investigated. Nonetheless, these re-
sults strongly argue that hUbc9 and MPMV Gag interact in
mammalian cells near the nuclear membrane.
In addition to its sumoylating activity, Ubc9 is known to
shuttle between the cytoplasm and nucleus and to associate
with nuclear pores (Zhang et al., 2002). In doing so, Ubc9
plays a role in intracellular trafficking of substrate proteins
to the nuclear compartment, to the kinetochores, and to
microtubule organizing centers (Joseph et al., 2002; Kurtz-
man and Schechter, 2001; Melchior, 2000; Rangasamy et
al., 2000; Saitoh et al., 1998; Zhang et al., 2002). Because
MPMV Gag is known to assemble in the cytoplasm in the
vicinity of the nuclear membrane, we envision several pos-
sible functions for hUbc9 during MPMV replication. First,
hUbc9 might target a fraction of Pr78 molecules to the
Fig. 4. Subcellular localization of Gag and Myc-tagged Ubc9. (A-E) COS-1 cells were transfected with pCMV. Myc-Ubc9 alone (A and B) or cotransfected
with pSHRM15 and pCMV. Myc-hUbc9 (C–E), fixed at 48 h posttransfection, and stained with monoclonal anti-Myc (A, B, C, and F) and polyclonal
anti-Pr78 (D and G) antibodies. Polyclonal and monoclonal antibodies were stained with secondary Cy2-conjugated anti-rabbit and Cy5-conjugated
anti-mouse antibodies, respectively, and cells were visualized by confocal microscopy. (D–I) HeLa cells were contransfected with pCMV.Myc-Ubc9 and
pSHRM15 and prepared in an identical manner but were visualized as a 1-m-thick confocal z-stack. A representative focal section through the nuclear plane
is shown (F–H). Cy2 and Cy5 channels were recorded separately and merged digitally (E and H). (I–M) CMMT cells were left untreated (I and L) or treated
with sodium azide and 2-deoxy-D-glucose (K and M) for 1 h to deplete intracellular ATP pools. The subcellular localization of Pr78 (I and K) was detected
as described for (A). Phase images of the cells in (I) and (K) show the positions of the nuclei (L and M, respectively).
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nuclear pore where they bind to unspliced and untranslated
viral RNAs as the RNAs exit the nucleus. This Gag–RNA
complex could then serve as a nucleation site for procapsid
assembly. Such a scenario would explain how Gag proteins
and ribosomes compete for the viral RNA for packaging or
translation. Second, Ubc9 might target Pr78 into the nucleus
where viral RNA recognition might first occur, as suggested
by Scheifele et al. (2002). In this scenario, Pr78 would need
to contain nuclear import and export signals. Sequences
resembling a basic import signal and a leucine-rich export
signal are present in MPMV Gag. Whether these are func-
tional nuclear import and export signals is currently being
examined. Finally, Ubc9, either directly or indirectly
through its sumoylation activity, might be involved in trans-
porting Pr78 (or possibly assembled procapsids) to micro-
tubule organizing centers for eventual transport to the
plasma membrane. The fact that MPMV Gag is capable of
interacting with the microtubule-associated motor protein,
KIF4, in a two-hybrid assay is consistent with this possi-
bility (Kim et al., 1998).
Ubc9 might also play an important role during the early
stages of MPMV replication. For example, Ubc9, through
its sumoylation activity, might modify Gag proteins of the
PIC and as result control targeting of the PIC to the nuclear
compartment. Whether Pr78 and/or its cleavage products
are sumoylated in infected cells is currently being investi-
gated. Alternatively, Ubc9 might target the PIC to mitotic
spindles via sumoylation much in the same way as nuclear
targeting of RanGAP1 requires sumoylation (Joseph et al.,
2002). In this model, the PIC would remain associated with
the chromatin during nuclear reassembly and thus be poised
for proviral integration. The models presented here are not
mutually exclusive; Ubc9 might play dual roles in assembly
and at some postentry step. If Ubc9 is indeed essential for
retroviral replication, it would present a target for the design
of rational antiviral therapeutics.
Materials and methods
Cell lines, bacteria, and yeast strains
COS-1 and HeLa cells were cultured in DMEM medium
supplemented with 10% fetal bovine serum. CMMT cells,
which produce infectious M-PMV, were cultured in RPMI
1640 supplemented with 5% tryptose phosphate broth and
10% fetal bovine serum. For ATP depletion studies, CMMT
cells were treated with 10 mM sodium azide and 6 mM
2-deoxy-D-glucose in glucose-free RPMI 1640 as previ-
ously described (Weldon et al., 1998b). Escherichia coli
LeuB-HB101 strain was used for selection of the
pGAD424-plasmids (prey plasmids) isolated from yeast. E.
coli BL21 (DE3) strain was used for recombinant GST–
fusion protein expression. Plasmid propagation was per-
formed in E. coli DH1, DH5, or JM109 strains. Saccha-
romyces cerevisiae Y187, Y190, and CG1945 strains
(Clontech) containing the Gal4 promoter-dependent select-
able markers LacZ and HIS3 (stains Y190 and CG1945
only) were used for the yeast two-hybrid experiments.
DNAs
The bacterial expression plasmid pET.M100A encodes a
carboxy-terminal His-tagged MPMV Gag protein (Sakalian
and Hunter, 1999). Plasmids pSHRM15 and pSARM4 are
infectious molecular clones of wild-type MPMV (kind gift
from E. Hunter, University of Alabama, Birmingham, AL).
Antibodies
Polyclonal anti-Pr78 has previously been described
(Sakalian et al., 1996; Weldon et al., 1998b). Polyclonal and
monoclonal antibodies to hUbc9 and Tsg101 were obtained
from either Signal Transduction Laboratories or Santa Cruz
Biotechnology. HRP-conjugated GST antibodies and HRP-
conjugated goat anti-rabbit and anti-mouse antibodies were
purchased from Amersham Pharmacia. Cy2 and Cy5-con-
jugated anti-rabbit and anti-mouse antibodies were obtained
from Jackson Immunoresearch Laboratories.
Two-hybrid screening
For the yeast two-hybrid screen, the MPMV gag gene
was inserted into the bait vector pAS2.1 (Clontech), which
fuses the GAL4 DNA-binding domain to the amino-termi-
nal end of the Gag protein. For this, the NC-p4 coding
region contained within an NcoI-XhoI fragment of
pETM100A was subcloned into the NcoI-SaII sites in
pAS2.1 (Clontech) to create pAS.NCp4. To subclone the
MA-CA region gag, the NcoI-NcoI fragment of pET.M100A
was subcloned into the NcoI site of pAS.NCp4 to create
pAS.Gag. The MPMV gag gene was similarly cloned into
the yeast Gal4 activation domain plasmid, pGADGH, to
create pMPAD. A commercially available HeLa cDNA
library cloned into pGADGH (Clontech) was used to screen
for cDNAs that encode potential MPMV Gag-interacting
cellular proteins. This library had a complexity of 7  106
independent clones.
The Matchmaker 2 system (Clontech) was used for the
yeast two-hybrid screen according to manufacturer’s sug-
gestions. S. cerevisiae CG1945 strain was transformed with
pAS.Gag and selected on minimal medium lacking trypto-
phan. Gal4–Gag fusion protein expression in yeast was
confirmed by immunoblot analysis using anti-Gag antibod-
ies (data not shown). Cells were subsequently transformed
with the cDNA library and selected on minimal media
lacking leucine and tryptophan. Duplicate samples were
plated on minimal media lacking leucine, tryptophan, and
histidine and supplemented with -galactosidase and 5 mM
3AT to select for potential Gag-interacting partners. A total
of 2.5  107 transformants were screened for reporter gene
activities. Of the resulting 348 colonies that were His3 and
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-gal (filter assays), 25 were selected that showed depen-
dence on the Gal4–Gag fusion protein for activation of the
reporter genes. After three successive platings on selective
media to ensure the isolation of pure cultures, plasmid
DNAs were isolated and used to transform E. coli LeuB-
BH101. Transformed bacteria were plated on minimal me-
dia lacking leucine for selection of the pGADGH-cDNA
plasmids. Plasmid DNAs were isolated from these bacteria
and retransformed into S. cerevisiae (either Y187 strain for
-gal assays or Y190 strain for HIS3 selection) containing
either pAS.Gag (to confirm positive results), pVA3 (encod-
ing p53), pLAM5 (human lamin C), or the empty prey
plasmid pAS2.1 as controls. Plasmids containing the
cDNAs encoding fusion proteins that specifically interacted
with Gag were isolated and sequenced. DNA sequence
analysis and BLAST DNA and amino acid homology
searches using this common open reading frame revealed
that 15 of these clones were identical to human ubc9. cDNA
clone G10B contained the entire, non-permuted hUbc9 cod-
ing sequence and was chosen for further studies.
Mammalian, in vitro, and bacterial expression plasmids
For mammalian expression of Myc epitope-tagged
hUbc9, the wild-type hUbc9 open reading frame, contained
within an EcoRI-XhoI fragment from the cDNA clone
pG10B, was subcloned into the EcoRI-SalI restriction sites
of pCMV.Tag 3A (Stratagene) to create pCMV.Myc-
hUbc9. For bacterial expression of hUbc9–GST fusion pro-
teins, the hUbc9 open reading frame in pCMV.Myc-hUbc9
was excised as a PstI-XhoI fragment and subcloned into the
corresponding sites of pET.41C() (Novagen) to create
pET.Ubc9. The inserts of all newly constructed plasmid
DNAs were sequenced to ensure that unwanted mutations
were not inadvertently created. Expression of Myc–hUbc9
and hUbc9–GST fusion proteins in mammalian and bacte-
rial cells, respectively, was confirmed by immunoblot anal-
yses using anti-Myc, anti-GST, and anti-Ubc9 antibodies
(data not shown).
In vitro transcription/translation of MPMV Gag
Transcription and translation reactions were performed
simultaneously with pETM100A and the Coupled TNT Re-
ticulocyte Lysate System (Promega) according to the man-
ufacturer’s instructions.
Bacterial expression and purification of GST-fusion
proteins
E. coli BL21 (DE3) cells were transformed with either
pET.Ubc9 or pET41c(). Five hundred milliliter cultures of
cells harboring either pET.Ubc9 or pET41C were grown
to an optical density at 600 nm of 0.7, induced by the
addition of 0.1 M isopropyl--D-thiogalactopyranoside
(IPTG) and incubated at 37°C for 3.5 h. Cells were chilled
on ice, harvested by centrifugation at 6693 g for 15 min, and
resuspended in 12.5 ml BugBuster reagent containing Ben-
zonase Nuclease and rlysozyme (Novagen). Cells were
lysed at room temperature for 20 min with gentle rocking.
Cell debris was removed by centrifugation at 16,000 g (4°C)
for 20 min. GST and hUbc9–GST fusion proteins were
bound to glutathione–Sepharose (250 l of settled resin per
500 ml culture; Novagen) for 8 h at 4°C with gentle rocking.
Beads were washed with 20 column volumes of GBW
buffer (4.3 mM Na2HPO4, 1.47 mM KH2PO4, 275 mM
NaCl, 2.7 mM KCl, pH 7.3) and eluted with 10 mM reduced
glutathione (in 50 mM Tris–Cl, pH 8.0) according to man-
ufacturer’s suggestions. Reduced glutathione was removed
by dialysis using three buffer (50 mM Tris–Cl, pH 8.0)
changes. The purities and concentrations of the purified
proteins were estimated by SDS–PAGE/Sypro orange (Bio-
Rad Laboratory) staining and Lowry protein assays.
GST pull-down assays
To perform the GST pull-down experiments, approxi-
mately equal molar amounts of purified GST (12 g) or
hUbc9–GST (17 g) were bound to 20 l settled glutathio-
ne–Sepharose (Novagen) in 500 l of GBW buffer. The
resin was washed once with 1 ml GBW buffer and then
incubated for 15 min with BSA (0.2 mg/ml) to block non-
specific protein-binding sites.
Reduced glutathione–Sepharose bound GST (12 g) or
Ubs9–GST (17 g) fusion proteins were incubated (8 h at
4°C) with either pSARM4-transfected cell lysates, in vitro
translation reactions containing Pr78, or 20 ng Gag-cleav-
age proteins obtained from purified MPMV virions that
were solubilized in GTN buffer (GBW buffer, 275 mM
NaC, 10.5% TX-100, 0.1% BSA). Beads were washed twice
in GTN buffer and once in modified GBW buffer (same as
GBW but with 135 mM NaCl). Bound proteins were eluted
with protein sample buffer [10% glycerol, 2.3% SDS, 63
mM Tris–HCl (pH 6.8), 5% -mercaptoethanol, 0.01%
bromphenol blue] and separated by SDS–PAGE using ei-
ther 12 or 15% acrylamide gels (Weldon et al., 1990).
MPMV Gag proteins were analyzed by immunoblot analy-
ses using polyclonal antibodies to Pr78, horseradish perox-
idase (HRP) conjugated anti-rabbit antibodies, and Western
Lighting (Perkin–Elmer) chemiluminescence reagent in ac-
cordance with manufacturer’s suggestions. Polyclonal anti-
sera against Pr78- and HRP-conjugated goat anti-rabbit im-
munoglobulin G were used at 1:10,000 and 1:30,000
dilutions, respectively. Blots were quantitated by densito-
metric analyses using a FluorS multi-imaging system and
Quantity One software (Bio-Rad).
Transfection and cell lysis
CMMT cells and either COS-1 cells or HeLa cells
(100-mm plates) were transfected with Fugene 6 and 2 g
pSARM4 (or pSHRM15). At 48 h posttransfection, media
70 R.A. Weldon Jr. et al. / Virology 314 (2003) 62–73
were removed and cells were lysed on ice for 30 min with
GTN buffer containing PMSF, leupeptin, pepstatin, and
aprotinin. Cell lysates were clarified in a microcentrifuge for
2 min.
Coimmunoprecipitation of Gag and hUbc9–GST fusion
proteins
Uninfected HeLa cells, pSARM4-transfected HeLa cells,
and MPMV virions (approximately 20 ng total Gag-related
proteins) were lysed on ice for 30 min with GTN buffer.
Samples were incubated with approximately equal molar
amounts of soluble GST (12 g) or hUbc9–GST (17 g)
proteins in GTN buffer containing 0.1% BSA. After incu-
bation for 8 h at 4°C with gentle rocking, 1 l of anti-Pr78
polyclonal antisera was added. Samples were incubated for
an additional 4 h on ice. Antibody–antigen complexes were
collected with formalin-fixed saccharomyces aureus cells
(Sakalian et al., 1996a), washed twice in GTN buffer, once
in 20 mM Tris–Cl (pH 6.3), separated by SDS–PAGE, and
analyzed by immunoblot analyses using HRP-conjugated
anti-GST antibodies (1:10,000 dilution).
Virus purification
Tissue culture media were harvested from confluent
monolayers of CMMT cells. After removing the cell debris
by centrifugation at 6000 g for 10 min, virions were pelleted
by centrifugation in a type 21 rotor (Beckman Instruments)
at 21,000 rpm for 1 h at 4°C. The viral pellets were resus-
pended in PBS and layered onto continuous 20 to 60%
(wt/wt) sucrose gradients in PBS. Gradients were centri-
fuged in a SW41 rotor (Beckman Instruments) for 16 h at
31,000 rpm at 4°C. Visible viral bands were collected,
diluted fourfold in PBS, pelleted by centrifugation as above,
and resuspended in PBS. Isopycnic-banded viruses were
further purified by velocity sedimentation through continu-
ous 5–20% (wt/wt) sucrose gradients by centrifugation in a
SW41 rotor for 30 min at 31,000 rpm (4°C). Viral bands
were collected, pelleted, and resuspended in PBS.
Subcellular localization
HeLa and COS-1 cells were transfected for 48 h with
pCMV.Myc-Ubc9 alone or in combination with pSARM4
using Fugene 6 (Boehringer Mannheim) according to man-
ufacturer’s suggestions. Cells were grown on coverslips,
washed twice in PBS, fixed with 4% paraformaldehyde in
PBS for 10 min at room temperature, and washed again in
PBS. The cells were then permeabilized with 100% ethanol
(20°C) for 2 min, rehydrated with PBS, washed with PBS
 0.1% BSA, and incubated with primary antibodies, either
a monoclonal anti-myc (1:60 dilution) and/or polyclonal
anti-Pr78 (1:100 dilution), for 30 min at room temperature.
Primary antibodies were detected using Cy2-labeled anti-
rabbit IgG and Cy5-labeled anti-mouse IgG antibodies.
Coverslips were mounted with Gel-mount and analyzed by
confocal microscopy (Bio-Rad MRC 1024 ES microscope)
using excitation wavelengths 506 nm (Cy2) and 670 nm
(CY5). The channels were recorded separately and merged
digitally.
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